Home
>
US Stocks
>
Celsius Holdings Inc

Celsius Holdings Inc (CELH)

$133.29

+7.76

(+6.18%)▲

Market is closed - opens 7 PM, 02 Jun 2023

Insights on Celsius Holdings Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 188.23M → 177.96M (in $), with an average decrease of 2.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -181.89M → -21.22M (in $), with an average increase of 378.5% per quarter

Performance

  • $126.18
    $136.56
    $133.29
    downward going graph

    5.34%

    Downside

    Day's Volatility :7.6%

    Upside

    2.39%

    downward going graph
  • $52.11
    $138.80
    $133.29
    downward going graph

    60.9%

    Downside

    52 Weeks Volatility :62.46%

    Upside

    3.97%

    downward going graph

Returns

PeriodCelsius Holdings IncSector (Consumer Staples)Index (Russel 2000)
3 Months
41.39%
1.6%
-6.8%
6 Months
10.72%
-5.4%
-6.0%
1 Year
90.57%
-1.1%
-4.6%
3 Years
1312.04%
21.8%
25.9%

Highlights

Market Capitalization
9.7B
Book Value
$1.06
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.28
PEG Ratio
0.0
Wall Street Target Price
134.18
Profit Margin
-19.58%
Operating Margin TTM
-15.45%
Return On Assets TTM
-9.21%
Return On Equity TTM
-26.94%
Revenue TTM
780.2M
Revenue Per Share TTM
10.26
Quarterly Revenue Growth YOY
94.89999999999999%
Gross Profit TTM
270.9M
EBITDA
-118.4M
Diluted Eps TTM
-2.28
Quarterly Earnings Growth YOY
3.51
EPS Estimate Current Year
1.32
EPS Estimate Next Year
2.23
EPS Estimate Current Quarter
0.2
EPS Estimate Next Quarter
0.26

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 17 Wall street analysts offering stock ratings for Celsius Holdings Inc(by analysts ranked 0 to 5 stars)
Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
14
12
Hold
2
2
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 0.67%

Current $133.29
Target $134.18

Company Financials

FY17Y/Y Change
Revenue
36.2M
↑ 58.89%
Net Income
-8.2M
↑ 168.63%
Net Profit Margin
-22.79%
↓ 9.31%
FY18Y/Y Change
Revenue
52.6M
↑ 45.46%
Net Income
-11.2M
↑ 35.99%
Net Profit Margin
-21.3%
↑ 1.49%
FY19Y/Y Change
Revenue
75.1M
↑ 42.85%
Net Income
10.0M
↓ 188.98%
Net Profit Margin
13.27%
↑ 34.57%
FY20Y/Y Change
Revenue
130.7M
↑ 73.96%
Net Income
8.5M
↓ 14.52%
Net Profit Margin
6.52%
↓ 6.75%
FY21Y/Y Change
Revenue
314.3M
↑ 140.41%
Net Income
3.9M
↓ 53.81%
Net Profit Margin
1.25%
↓ 5.27%
FY22Y/Y Change
Revenue
653.6M
↑ 107.97%
Net Income
-187.3M
↓ 4856.64%
Net Profit Margin
-28.65%
↓ 29.9%
Q4 FY21Q/Q Change
Revenue
104.3M
↑ 9.85%
Net Income
-3.4M
↓ 222.16%
Net Profit Margin
-3.22%
↓ 6.11%
Q1 FY22Q/Q Change
Revenue
133.4M
↑ 27.94%
Net Income
6.7M
↓ 299.12%
Net Profit Margin
5.01%
↑ 8.23%
Q2 FY22Q/Q Change
Revenue
154.0M
↑ 15.47%
Net Income
9.2M
↑ 37.12%
Net Profit Margin
5.95%
↑ 0.94%
Q3 FY22Q/Q Change
Revenue
188.2M
↑ 22.21%
Net Income
-181.9M
↓ 2086.2%
Net Profit Margin
-96.63%
↓ 102.58%
Q4 FY22Q/Q Change
Revenue
178.0M
↓ 5.46%
Net Income
-21.2M
↓ 88.33%
Net Profit Margin
-11.93%
↑ 84.7%
Q1 FY23Q/Q Change
Revenue
178.0M
↑ 0.0%
Net Income
-21.2M
↑ 0.0%
Net Profit Margin
-11.93%
↑ 0.0%
FY17Y/Y Change
Total Assets
27.1M
↑ 53.02%
Total Liabilities
10.0M
↑ 46.04%
FY18Y/Y Change
Total Assets
34.6M
↑ 27.73%
Total Liabilities
22.8M
↑ 129.08%
FY19Y/Y Change
Total Assets
90.4M
↑ 161.01%
Total Liabilities
26.9M
↑ 17.96%
FY20Y/Y Change
Total Assets
131.3M
↑ 45.26%
Total Liabilities
27.0M
↑ 0.15%
FY21Y/Y Change
Total Assets
314.0M
↑ 139.18%
Total Liabilities
97.0M
↑ 259.66%
FY22Y/Y Change
Total Assets
1.2B
↑ 289.17%
Total Liabilities
357.5M
↑ 268.65%
Q4 FY21Q/Q Change
Total Assets
314.0M
↑ 6.45%
Total Liabilities
97.0M
↓ 0.62%
Q1 FY22Q/Q Change
Total Assets
343.9M
↑ 9.52%
Total Liabilities
115.6M
↑ 19.18%
Q2 FY22Q/Q Change
Total Assets
349.6M
↑ 1.66%
Total Liabilities
109.8M
↓ 5.02%
Q3 FY22Q/Q Change
Total Assets
1.3B
↑ 279.72%
Total Liabilities
443.7M
↑ 304.24%
Q4 FY22Q/Q Change
Total Assets
1.2B
↓ 7.95%
Total Liabilities
357.5M
↓ 19.43%
Q1 FY23Q/Q Change
Total Assets
1.2B
↑ 0.0%
Total Liabilities
357.5M
↑ 0.0%
FY17Y/Y Change
Operating Cash Flow
-8.4M
↑ 256.19%
Investing Cash Flow
-49.5K
↑ 114.71%
Financing Cash Flow
10.9M
↑ 173.3%
FY18Y/Y Change
Operating Cash Flow
-11.6M
↑ 38.35%
Investing Cash Flow
-110.4K
↑ 122.91%
Financing Cash Flow
5.3M
↓ 51.57%
FY19Y/Y Change
Operating Cash Flow
1.0M
↓ 108.88%
Investing Cash Flow
-14.3M
↑ 12820.14%
Financing Cash Flow
28.7M
↑ 440.52%
FY20Y/Y Change
Operating Cash Flow
3.4M
↑ 228.35%
Investing Cash Flow
757.3K
↓ 105.31%
Financing Cash Flow
15.6M
↓ 45.66%
FY21Y/Y Change
Operating Cash Flow
-96.6M
↓ 2944.89%
Investing Cash Flow
-1.3M
↓ 267.0%
Financing Cash Flow
71.4M
↑ 358.5%
FY22Y/Y Change
Operating Cash Flow
108.2M
↓ 212.01%
Investing Cash Flow
-5.7M
↑ 348.5%
Financing Cash Flow
534.1M
↑ 648.1%
Q4 FY21Q/Q Change
Operating Cash Flow
-44.5M
↑ 104.85%
Investing Cash Flow
-755.1K
↓ 35.45%
Financing Cash Flow
456.4K
↓ 35.2%
Q1 FY22Q/Q Change
Operating Cash Flow
9.1M
↓ 120.5%
Investing Cash Flow
-742.0K
↓ 1.73%
Financing Cash Flow
790.0K
↑ 73.11%
Q2 FY22Q/Q Change
Operating Cash Flow
33.2M
↑ 263.52%
Investing Cash Flow
878.0K
↓ 218.33%
Financing Cash Flow
433.0K
↓ 45.19%
Q3 FY22Q/Q Change
Operating Cash Flow
128.7M
↑ 287.9%
Investing Cash Flow
-1.0M
↓ 216.29%
Financing Cash Flow
539.3M
↑ 124439.03%
Q4 FY22Q/Q Change
Operating Cash Flow
-62.8M
↓ 148.79%
Investing Cash Flow
-4.8M
↑ 368.85%
Financing Cash Flow
-6.4M
↓ 101.18%
Q1 FY23Q/Q Change
Operating Cash Flow
-62.8M
↑ 0.0%
Investing Cash Flow
-4.8M
↑ 0.0%
Financing Cash Flow
-6.4M
↑ 0.0%

Technicals Summary

Sell

Neutral

Buy

Celsius Holdings Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Celsius Holdings Inc
Celsius Holdings Inc
21.46%
10.72%
90.57%
1312.04%
2570.85%
Coca-Cola Europacific Partners
Coca-Cola Europacific Partners
-3.66%
16.2%
17.14%
1.63%
1.63%
Pepsico, Inc.
Pepsico, Inc.
-4.87%
-1.91%
9.53%
37.12%
81.9%
Coca-Cola Company, The
Coca-Cola Company, The
-7.22%
-6.47%
-5.41%
26.96%
38.36%
Keurig Dr Pepper Inc
Keurig Dr Pepper Inc
-4.45%
-19.61%
-10.16%
9.73%
-74.05%
Monster Beverage Corporation
Monster Beverage Corporation
3.13%
13.55%
33.15%
61.51%
127.65%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Celsius Holdings Inc
Celsius Holdings Inc
356.16
NA
0.0
1.32
-0.27
-0.09
0.0
1.06
Coca-Cola Europacific Partners
Coca-Cola Europacific Partners
17.53
17.53
NA
3.86
0.21
0.05
0.03
16.29
Pepsico, Inc.
Pepsico, Inc.
38.23
38.23
3.1
7.32
0.37
0.08
0.03
12.37
Coca-Cola Company, The
Coca-Cola Company, The
26.33
26.33
3.6
2.61
0.37
0.08
0.03
5.83
Keurig Dr Pepper Inc
Keurig Dr Pepper Inc
33.33
33.33
3.19
1.78
0.05
0.03
0.03
17.88
Monster Beverage Corporation
Monster Beverage Corporation
47.66
47.66
3.4
1.54
0.18
0.12
0.0
7.07
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Celsius Holdings Inc
Celsius Holdings Inc
Buy
$9.7B
2570.85%
356.16
-19.58%
Coca-Cola Europacific Partners
Coca-Cola Europacific Partners
Buy
$28.7B
1.63%
17.53
8.71%
Pepsico, Inc.
Pepsico, Inc.
Buy
$250.2B
81.9%
38.23
7.48%
Coca-Cola Company, The
Coca-Cola Company, The
Buy
$258.5B
38.36%
26.33
22.69%
Keurig Dr Pepper Inc
Keurig Dr Pepper Inc
Buy
$43.5B
-74.05%
33.33
9.2%
Monster Beverage Corporation
Monster Beverage Corporation
Buy
$61.4B
127.65%
47.66
19.95%

Institutional Holdings

  • FMR Inc

    9.54%

  • BlackRock Inc

    6.78%

  • Vanguard Group Inc

    5.25%

  • State Street Corporation

    2.04%

  • Hood River Capital Management LLC

    1.88%

  • Wellington Management Company LLP

    1.49%

Company Information

Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CELSIUS® has five beverage lines that each offer proprietary, functional, healthy-energy formulas clinically-proven to offer significant health benefits to its users. The five lines include, CELSIUS® Originals, CELSIUS HEAT™, CELSIUS® BCAA +Energy, CELSIUS® On-the-Go, and CELSIUS® Sweetened with Stevia. CELSIUS® has zero sugar, no preservatives, no aspartame, no high fructose corn syrup, and is non-GMO, with no artificial flavors or colors. The CELSIUS® line of products is Certified Kosher and Vegan. CELSIUS® is also soy and gluten-free and contains very little sodium. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. CELSIUS® is sold nationally at Target, CVS, Walmart, GNC, Vitamin Shoppe, 7-Eleven, Dick's Sporting Goods, The Fresh Market, Sprouts and other key regional retailers such as HEB, Publix, Winn-Dixie, Harris Teeter, Shaw's and Food Lion. It is also available on Amazon, at fitness clubs and in select micro-markets across the country.

Organization
Celsius Holdings Inc
Employees
378
CEO
Mr. John Fieldly
Industry
Consumer Non-Durables

Discover More

FAQs